Mideplanin

Mideplanin (MDL 62873) is an antimicrobial agent, semisynthetic amide derivative of Teicoplanin (HY-A0097) . Mideplanin is highly active in vitro against staphylococci[1].

Product Specifications

CAS Number

[122173-74-4]

Product Name Alternative

MDL 62873

UNSPSC

12352005

Target

Bacterial; Drug Derivative

Related Pathways

Anti-infection; Others

Applications

COVID-19-immunoregulation

Field of Research

Infection

Smiles

CN(C)CCCNC(C(NC(C(N1)C(C2=CC=C(OC3=C(OC4C(C(C(O)C(CO)O4)O)NC(CCCCCCC(C)C)=O)C5=CC(C(NC(C(N6)C7=CC(O)=CC(OC8=C(O)C=CC(C(N)C(NC(CC9=CC=C(O5)C(Cl)=C9)C6=O)=O)=C8)=C7)=O)C(NC%10C1=O)=O)=C3)C(Cl)=C2)OC%11C(C(C(O)C(CO)O%11)O)NC(C)=O)=O)C%12=CC(O)=CC(OC%13OC(C(O)C(O)C%13O)CO)=C%12C%14=CC%10=CC=C%14O)=O

Molecular Formula

C93H109Cl2N11O32

Molecular Weight

1963.82

References & Citations

[1]Biavasco F, et al. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873. Antimicrob Agents Chemother. 1992 Feb;36 (2) :331-8.